Frog Foam Could be Used to Boost Health Treatments

Foam made by tiny frogs could be used to deliver antibiotics to help prevent infections, research involving the University of Strathclyde has found. At the Microbiology Society’s Annual Conference in Liverpool, Strathclyde scientists Dr Paul Hoskisson and Sarah Brozio unveiled their study showing how the foam made by Trinidadian frogs could have important health applications. [...]

By |2016-04-03T03:08:16+00:00April 3rd, 2016|Antibiotics, Drug Discovery, Infection, Treatment|Comments Off on Frog Foam Could be Used to Boost Health Treatments

Research to Assess Scottish Plants in Fight Against Cancer

Health researchers at Robert Gordon University (RGU) have been awarded funding of almost £10,000 to investigate whether Scottish plants could hold the key to increasing the effectiveness of cancer drugs and boosting survival rates. A research team led by Dr Gemma Barron has received £9,800 from medical research funding charity Tenovus Scotland Grampian for an 18 -month project which [...]

By |2016-03-30T15:38:48+00:00March 30th, 2016|Cancer, Drug Discovery|Comments Off on Research to Assess Scottish Plants in Fight Against Cancer

Cellular Role of Priority Parkinson’s Disease Drug Target Identified

An international public-private consortium of researchers brought together by the University of Dundee and led by The Michael J. Fox Foundation for Parkinson’s Research has identified and validated for the first time the cellular role of a primary Parkinson’s disease drug target. In work published in eLife, the team comprising investigators from the University of Dundee, Max [...]

By |2016-03-29T13:29:45+00:00March 29th, 2016|Disease, Drug Discovery, Neurology|Comments Off on Cellular Role of Priority Parkinson’s Disease Drug Target Identified

New Research Could Lead to Drug Targets in Pain Medication

An international team of scientists have provided insights into the working of a ‘signaling molecule’, which will provide new strategies for medicines in areas such as pain medication. In a study published in Nature, the team, led by scientists at the University Würzburg, Germany and including the University of Glasgow, have discovered that β-arrestins are [...]

By |2016-03-27T01:42:12+00:00March 27th, 2016|Dementia, Diabetes, Drug Discovery, Pain|Comments Off on New Research Could Lead to Drug Targets in Pain Medication

Newcastle Drug Development Programme Receives Investment to Help Boys with Rare Illness

Millions of pounds have been invested in a drug development programme to help boys with a rare life-limiting disease. The John Walton Muscular Dystrophy Research Centre at Newcastle University has received £4.6 million from the European Commission for a pioneering clinical trial into the new drug, vamorolone. The European project, called VISION-DMD, involves 10 countries [...]

By |2016-03-23T16:22:51+00:00March 23rd, 2016|Disease, Drug Discovery|Comments Off on Newcastle Drug Development Programme Receives Investment to Help Boys with Rare Illness

Experts Call for Clinical Trials Rethink

Researchers have outlined lessons that can be learned from a drug testing trial in which a person died. The experts are urging a review of how tests for new medicines – so-called first-in-human clinical trials – are assessed, following the tragedy in France in January that also left four people seriously ill. Writing in the [...]

By |2016-03-20T23:06:32+00:00March 20th, 2016|Clinical Trial, Drug Discovery|Comments Off on Experts Call for Clinical Trials Rethink

Pharmaceutical Industry’s Contribution Towards NHS Medicines Bill Hits £1 Billion

New figures from the Association of the British Pharmaceutical Industry, show that the pharmaceutical industry has contributed over £1 billion to the Department of Health towards the cost of new medicines as part of the voluntary Pharmaceutical Payment Regulation Scheme (PPRS). The scheme is intended to help make the latest treatments affordable for NHS patients [...]

By |2016-03-13T21:25:23+00:00March 13th, 2016|Drug Discovery|Comments Off on Pharmaceutical Industry’s Contribution Towards NHS Medicines Bill Hits £1 Billion

FIFE CENTENARIAN JOINS EFFORT TO SHAPE FUTURE MEDICINES

A North Queensferry woman has become the oldest person to join a Scotland-wide effort to help shape the medicines of the future. 100-year old Isabella Moore and her two daughters signed up to The Scottish Health Research Register (SHARE) during a visit to the Queen Margaret Hospital, Dunfermline. SHARE aims to make it easier for [...]

By |2016-03-09T16:29:58+00:00March 9th, 2016|Drug Discovery|Comments Off on FIFE CENTENARIAN JOINS EFFORT TO SHAPE FUTURE MEDICINES

Lorraine Kelly Becomes 100,000th Volunteer to Join SHARE

Television presenter – and former Rector of the University of Dundee – Lorraine Kelly has become the 100,000th volunteer to join a Scotland-wide effort to help shape the medicines of the future. SHARE (The Scottish Health Research Register) is a unique initiative which aims to make it easier for researchers to identify suitable recruits from Scotland [...]

By |2016-03-03T15:55:16+00:00March 3rd, 2016|Disease, Drug Discovery|Comments Off on Lorraine Kelly Becomes 100,000th Volunteer to Join SHARE

Eisai and Charles River Laboratories Announce Collaboration for New Drug Discovery

Eisai and Charles River Laboratories have announced that they have signed a collaboration agreement which will see Charles River scientists work at Eisai's research and development facilities in Hatfield, UK. The collaboration will involve Charles River supporting Eisai scientists from Japan, USA and the UK on a range of synthetic and medicinal chemistry projects, including those seeking novel treatments for neurological diseases. [...]

By |2016-02-18T16:40:21+00:00February 18th, 2016|Disease, Drug Discovery, Neurology, Research|Comments Off on Eisai and Charles River Laboratories Announce Collaboration for New Drug Discovery